CorMedix Inc. — Director's Dealing 2011

Nov 23, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2011-11-21

Reporting Person: Duffy Matthew (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-11-21	Stock Option (Right to Buy)	$0.28	A	30000	Acquired	2011-11-21	Common Stock, $0.001 par value per share (30000)	Direct

Footnotes

F1: The options vest ratably, one-third of which will vest on each of the grant date, the first anniversary and the second anniversary thereof.